-
公开(公告)号：US20230399383A1
公开(公告)日：2023-12-14
申请号：US18309475
申请日：2023-04-28
申请人： MEDIMMUNE LIMITED
发明人： Brian LOBO , Deborah GOLDBERG
IPC分类号： C07K16/10 , A61K39/395
CPC分类号： C07K16/10 , A61K39/39591 , C07K16/1027 , C07K2317/21 , C07K2317/94 , C07K2317/522 , C07K2317/92
摘要： The present invention provides a formulation comprising: (i) an anti-RSV monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater and the ionic excipient is present at a concentration of between 50 and 150 mM and the formulation has a pH of about 5.5 to about 7.5.
-
公开(公告)号：US20220204597A1
公开(公告)日：2022-06-30
申请号：US17455713
申请日：2021-11-19
申请人： MedImmune Limited
摘要： The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.
-
公开(公告)号：US20200283516A1
公开(公告)日：2020-09-10
申请号：US16488302
申请日：2018-02-28
申请人： MedImmune Limited
摘要： The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.
-
-
搜索结果
3 条记录 (耗时 0.009 秒)
